(SARS-CoV-2) virus pandemic and related coronavirus disease (COVID-19), have
dramatically altered health care delivery, worsened non–virusrelated health outcomes, and …

Importance Health care was disrupted in the US during the first quarter of 2020 with the
emergence of the COVID-19 pandemic. Early reports in selected samples suggested that …

Objectives To quantify the secondary impacts of the COVID-19 pandemic disruptions to
cervical cancer screening in the United States, stratified by step in the screening process …

The COVID-19 pandemic has contributed to decreases in breast, colorectal, and cervical
cancer screenings between 86 and 94% compared to three-year averages. These …

Purpose Screening is a major contributor to colorectal cancer (CRC) mortality reductions in
the United States but is underused. We estimated the fraction of CRC deaths attributable to …

The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to
continue for some time, with access to timely cancer-related services a concern. For breast …

Unquestionably, cancer should be diagnosed and treated without delay. Timely diagnosis
might allow the cancer to be identified at a treatable stage and prevent complications. This …

Background: Resource restrictions were established in many jurisdictions to maintain health
system capacity during the COVID-19 pandemic. Disrupted healthcare access likely …

Background Oncological care was considerably impacted by the COVID-19 pandemic.
Worrisome declines in diagnostic procedures and cancer diagnoses in 2020 have been …